Bioengineered 3D human kidney tissue, a platform for the determination of nephrotoxicity

Area of Science:

• Biotechnology
• Toxicology
• Renal Science

Background:

• High drug development costs and clinical trial failure rates necessitate improved preclinical toxicity models.
• Drug-induced nephrotoxicity is poorly predicted by current 2D cell cultures and animal models.
• Existing models fail to fully replicate in vivo human responses to drug toxicity.

Purpose of the Study:

• To bioengineer a 3D human kidney tissue model for enhanced drug toxicity prediction.
• To compare the efficacy of the 3D model against traditional 2D cultures for assessing nephrotoxicity.
• To evaluate the model's utility in predicting both acute and chronic renal toxicity.

Main Methods:

• Engineered a 3D kidney tissue model using immortalized human renal cortical epithelial cells.
• Assessed acute (3-day) and chronic (2-week) toxicity using Cisplatin, Gentamicin, and Doxorubicin.
• Measured toxicity via LDH secretion and biomarkers Kim-1 and NGAL, comparing 3D tissues to 2D cultures.

Main Results:

• The 3D kidney model demonstrated higher sensitivity to drug-induced nephrotoxicity compared to 2D cultures.
• The 3D model successfully monitored chronic toxicity from repeat drug dosing, unlike 2D cultures.
• Biomarkers Kim-1 and NGAL effectively assessed toxicity in the 3D tissue model.

Conclusions:

• The novel 3D kidney tissue model offers a more relevant human system for predicting drug nephrotoxicity.
• Integrating this model into preclinical drug testing can improve the identification of potential renal toxicants.
• This advancement may reduce late-stage drug failures and enhance patient safety during clinical trials.